ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection
OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…
Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid
Aurobindo Pharma announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per ml. The…
Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
Biocon Pharma, a subsidiary of Biocon, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Dapagliflozin Tablets, 5 mg and 10 mg. The…
SMS Pharma gains after Hyderabad facility completes USFDA inspection
SMS Pharmaceuticals rose 1.79% to Rs 221.80 after company announced that it has successfully completed a US Food and Drug Administration (USFDA) inspection at its API manufacturing facility located in…










